S100B and epilepsy: Given the fact that BBBD and subsequent S100B appearance is serum is a hallmark of many acute or chronic neurological diseases [39]–[45] as well as in animal model of seizures [13] or in human epilepsy [46], we wished to determine the fate of circulating S100B in control or post-status epilepticus animals.